Growth factor therapy for bones launched in the US
This article was originally published in Clinica
Executive Summary
Interpore Cross is gearing up to begin marketing a technology to make growth factors from patients' own blood for use in healing bone defects. This is thought to be the first commercially-available growth factor treatment for orthopaedic applications.